Literature DB >> 32227317

The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.

Jung Soo Lim1,2, William E Rainey1.   

Abstract

Primary aldosteronism (PA) is the most common cause of secondary hypertension. The hallmark of PA is adrenal production of aldosterone under suppressed renin conditions. PA subtypes include adrenal unilateral and bilateral hyperaldosteronism. Considerable progress has been made in defining the role for somatic gene mutations in aldosterone-producing adenomas (APA) as the primary cause of unilateral PA. This includes the use of next-generation sequencing (NGS) to define recurrent somatic mutations in APA that disrupt calcium signaling, increase aldosterone synthase (CYP11B2) expression, and aldosterone production. The use of CYP11B2 immunohistochemistry on adrenal glands from normal subjects, patients with unilateral and bilateral PA has allowed the identification of CYP11B2-positive cell foci, termed aldosterone-producing cell clusters (APCC). APCC lie beneath the adrenal capsule and like APA, many APCC harbor somatic gene mutations known to increase aldosterone production. These findings suggest that APCC may play a role in pathologic progression of PA. Herein, we provide an update on recent research directed at characterizing APCC and also discuss the unanswered questions related to the role of APCC in PA. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32227317      PMCID: PMC8029307          DOI: 10.1055/a-1128-0421

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  77 in total

1.  Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.

Authors:  Ravi Kumar Dutta; Jenny Welander; Michael Brauckhoff; Martin Walz; Piero Alesina; Thomas Arnesen; Peter Söderkvist; Oliver Gimm
Journal:  Endocr Relat Cancer       Date:  2014-01-08       Impact factor: 5.678

2.  Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.

Authors:  Elena A B Azizan; Brian Y H Lam; Stephen J Newhouse; Junhua Zhou; Rhoda E Kuc; Jennifer Clarke; Lisa Happerfield; Alison Marker; Gary J Hoffman; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

3.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 4.  Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.

Authors:  Silvia Monticone; Fabrizio D'Ascenzo; Claudio Moretti; Tracy Ann Williams; Franco Veglio; Fiorenzo Gaita; Paolo Mulatero
Journal:  Lancet Diabetes Endocrinol       Date:  2017-11-09       Impact factor: 32.069

Review 5.  Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.

Authors:  Yuhong Yang; Martin Reincke; Tracy Ann Williams
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-05       Impact factor: 4.690

6.  Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia.

Authors:  V C Wu; S C Chueh; H W Chang; W C Lin; K L Liu; H Y Li; Y H Lin; K D Wu; B S Hsieh
Journal:  QJM       Date:  2008-01

7.  Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na(+)/K(+)-ATPase.

Authors:  J Stindl; P Tauber; C Sterner; I Tegtmeier; R Warth; S Bandulik
Journal:  Endocrinology       Date:  2015-09-29       Impact factor: 4.736

8.  Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism.

Authors:  Na Sun; Lucie S Meyer; Annette Feuchtinger; Thomas Kunzke; Thomas Knösel; Martin Reincke; Axel Walch; Tracy Ann Williams
Journal:  Hypertension       Date:  2020-01-20       Impact factor: 10.190

9.  CLCN2 chloride channel mutations in familial hyperaldosteronism type II.

Authors:  Gabriel Stölting; Julia Schewe; Ute I Scholl; Anne Thiel; Hua Tan; Carol Nelson-Williams; Alfred A Vichot; Sheng Chih Jin; Erin Loring; Verena Untiet; Taekyeong Yoo; Jungmin Choi; Shengxin Xu; Aihua Wu; Marieluise Kirchner; Philipp Mertins; Lars C Rump; Ali Mirza Onder; Cory Gamble; Daniel McKenney; Robert W Lash; Deborah P Jones; Gary Chune; Priscila Gagliardi; Murim Choi; Richard Gordon; Michael Stowasser; Christoph Fahlke; Richard P Lifton
Journal:  Nat Genet       Date:  2018-02-05       Impact factor: 38.330

10.  CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.

Authors:  Georgios Daniil; Fabio L Fernandes-Rosa; Jean Chemin; Iulia Blesneac; Jacques Beltrand; Michel Polak; Xavier Jeunemaitre; Sheerazed Boulkroun; Laurence Amar; Tim M Strom; Philippe Lory; Maria-Christina Zennaro
Journal:  EBioMedicine       Date:  2016-10-04       Impact factor: 8.143

View more
  5 in total

Review 1.  DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases.

Authors:  Yoshimichi Takeda; Masashi Demura; Takashi Yoneda; Yoshiyu Takeda
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 2.  Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension.

Authors:  Fatin Athirah Pauzi; Elena Aisha Azizan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-03       Impact factor: 5.555

Review 3.  Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation.

Authors:  Martina Tetti; Siyuan Gong; Franco Veglio; Martin Reincke; Tracy Ann Williams
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

4.  Progress in Primary Aldosteronism 2019: New Players on the Block?

Authors:  Martin Reincke; Felix Beuschlein; Tracy Ann Williams
Journal:  Horm Metab Res       Date:  2020-06-16       Impact factor: 2.936

5.  Concurrence of overt Cushing's syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case report.

Authors:  Yoshiro Fushimi; Fuminori Tatsumi; Junpei Sanada; Masashi Shimoda; Shinji Kamei; Shuhei Nakanishi; Kohei Kaku; Tomoatsu Mune; Hideaki Kaneto
Journal:  BMC Endocr Disord       Date:  2021-08-12       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.